Belgium
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 847.68 M
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 491.02 M
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 429.36 M
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
4 |
USD 161.17 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
5 |
USD 72.47 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
The Biotechnology company in Belgium with the highest Receivables is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 847.68 M.
The Biotechnology company in Belgium with the lowest Receivables is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD 72.47 M.
The top 10 Biotechnology companies in Belgium by Receivables are UCB SA, Azelis Group NV, Tessenderlo Group NV, Ion Beam Applications SA and Galapagos NV.
The bottom 10 Biotechnology companies in Belgium by Receivables are Galapagos NV, Ion Beam Applications SA, Tessenderlo Group NV, Azelis Group NV and UCB SA.